The Central Procurement Board has acknowledged that no due diligence was done to determine whether companies selected for the tender have actual manufacturing plants or just exist on paper.

This was revealed by its Chairperson  Amon Ngavetene at a media conference today.

Addressing a media conference, Ngavetene says the process of awarding the controversial clinical products tender to selected bidders, is incomplete and subject to a review, following public outcry and several red flags.

This window period closed today and failure by any entity to submit an appeal for reconsideration, the deal will be sealed.

According to insiders, only the Head of State can exercise his executive powers to cancel controversial tenders.

Ngavetene explained that companies linked to the businessman Shapwa Kanyama were favoured because they are local manufacturers.

Kanyama was awarded the state tender worth 650 million dollars to among others supply condoms.